Obstetrics and gynecology
-
Obstetrics and gynecology · Jul 2018
Randomized Controlled TrialLong-Term Outcomes of Elagolix in Women With Endometriosis: Results From Two Extension Studies.
To evaluate the efficacy and safety of elagolix, an oral, nonpeptide gonadotropin-releasing hormone antagonist, over 12 months in women with endometriosis-associated pain. ⋯ ClinicalTrials.gov, NCT01760954 and NCT02143713.